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Escherichia coli O157:H7 is an important pathogen of humans. Cattle are most frequently identified as the
primary source of infection, and therefore, reduction in E. coli O157:H7 prevalence in cattle by vaccination
represents an attractive strategy for reducing the incidence of human disease. H7 flagella have been implicated
in intestinal-epithelial colonization of E. coliO157:H7 and may represent a useful target for vaccination. In this
study, calves were immunized either systemically with H7 flagellin by intramuscular injection or mucosally via
the rectum with either H7 or H7 incorporated into poly(DL-lactide-co-glycolide) microparticles (PLG:H7).
Systemic immunization resulted in high levels of flagellin-specific immunoglobulin G (IgG) and IgA in both
serum and nasal secretions and detectable levels of both antibody isotypes in rectal secretions. Rectal
administration of flagellin resulted in levels of rectal IgA similar to those by the intramuscular route but failed
to induce any other antibody response, whereas rectal immunization with PLG:H7 failed to induce any
H7-specific antibodies. Following subsequent oral challenge with E. coli O157:H7, reduced colonization rates
and delayed peak bacterial shedding were observed in the intramuscularly immunized group compared to
nonvaccinated calves, but no reduction in total bacterial shedding occurred. Rectal immunization with either
H7 or PLG:H7 had no effect on subsequent bacterial colonization or shedding. Furthermore, purified H7-
specific IgA and IgG from intramuscularly immunized calves were shown to reduce intestinal-epithelial
binding in vitro. These results indicate that H7 flagellin may be a useful component in a systemic vaccine to
reduce E. coli O157:H7 colonization in cattle.
Enterohemorrhagic Escherichia coli (EHEC) is a zoonotic
pathogen of worldwide importance, causing severe diarrhea
(hemorrhagic colitis) and, in a small percentage of cases, he-
molytic-uremic syndrome in humans. Ruminants are an impor-
tant reservoir of EHEC, and human infections are frequently
associated with direct or indirect contact with ruminant feces,
particularly those derived from cattle (16, 26, 34, 36). Coinci-
dentally, strategies to reduce the carriage of EHEC in rumi-
nants are predicted to lower the incidence of human disease
(reviewed in reference 36), and stochastic simulation models
predict that cattle are a key control point to reduce EHEC
infections in humans (22).
An attractive strategy to reduce EHEC colonization in cattle
is by vaccination. A number of EHEC vaccines have been
evaluated in cattle and have primarily focused on immuniza-
tion with bacterial proteins encoded by genes located within
the locus of enterocyte effacement (LEE) that are known to
play key roles in EHEC colonization of the bovine intestine (7,
13, 32, 41). These include immunization with recombinant
EspA (14), recombinant intimin (40), and a secreted protein
preparation containing Tir and proteins of the type III secre-
tion system (35). In addition, immunization with recombinant
EHEC factor for adherence (encoded by efa-1), another pro-
tein implicated in bovine intestinal colonization (37), and for-
malin-inactivated EHEC bacterin have been evaluated (40).
However, with the exception of immunization with the se-
creted protein preparation, which resulted in a reduction in
bacterial fecal shedding in calves following experimental chal-
lenge and reduced prevalence of EHEC in a small- but not a
large-scale field trial (39), all EHEC vaccines evaluated have
had no effect on subsequent EHEC colonization in cattle.
The reasons for the lack of success of EHEC vaccines to date
could be twofold. First, it may indicate that additional vaccine
targets are required. Second, as EHEC is nonpathogenic in
cattle and is restricted to the intestinal epithelium and gut
lumen (reviewed in reference 36), intestinal mucosal antibod-
ies to bacterial epithelial adhesins are likely to represent key
effectors for reduction of intestinal colonization in cattle. In-
deed, passive immunization of piglets with colostrum contain-
ing intimin-specific antibodies has been shown to confer resis-
tance to subsequent EHEC challenge, supporting a role for
mucosal antibodies in reducing bacterial colonization in vivo
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(10). However, in previous EHEC vaccine trials, antigen-spe-
cific mucosal antibody responses postimmunization either were
not measured (35) or were poor (14, 40). Therefore, the lack of
vaccine efficacy may in part be due to poor levels of antigen-
specific antibody at intestinal mucosal surfaces.
In North America and Europe, the predominant EHEC
serotype affecting humans is O157:H7 (1, 2). The principal site
of E. coli O157:H7 colonization in cattle is the terminal rectum
(31). Work in our laboratory has indicated that H7 flagella play
an important role in initial binding of E. coli O157:H7 to
bovine primary rectal epithelial cells in vitro (27), and Erdem
et al. have also recently demonstrated that the presence of H7
flagella is important in bacterial adherence to bovine intesti-
nal-tissue explants (15). Furthermore, H7 flagella have been
shown to play a role in E. coli O157:H7 colonization of chick-
ens in vivo (3), and flagella of a number of other bacteria,
including Clostridium difficile (38), Pseudomonas aeruginosa
(25), and enteropathogenic E. coli (17), have been demon-
strated to act as epithelial adhesins. Together, these observa-
tions suggest that H7 flagella may represent an additional
target for E. coli O157:H7 vaccination in cattle.
In this study, we evaluated the effects of systemic and mu-
cosal immunization with purified H7 flagellin, the main struc-
tural component of H7 flagella, on subsequent E. coli O157:H7
colonization in cattle. In an attempt to induce high levels of
mucosal antibodies at the principle site of colonization of E.
coli O157:H7 in cattle, i.e., the terminal rectum, mucosal im-
munizations with either H7 flagellin alone or H7 incorporated
into poly(DL-lactide-co-glycolide) (PLG) microparticles (PLG:
H7) were administered onto the rectal mucosa, which in cattle
possesses characteristics of an immune inductive site (28). Fur-
thermore, we performed a detailed analysis of H7-specific mu-
cosal antibody levels following immunizations using previously
validated mucosal sampling protocols (29).
MATERIALS AND METHODS
Purification of E. coli O157:H7 flagellin and encapsulation into PLG micro-
particles. Flagellin (H7) was isolated from E. coli O157:H7 (stx mutant) strain
ZAP984, a LEE4 deletion mutant derived from strain ZAP198 (32) by acid
dissociation, neutral-pH reassociation, and ammonium sulfate precipitation as
previously described (19). This protocol results in the purification of flagellin
monomers, which spontaneously repolymerize into flagellar filaments at neutral
pH. Purity was verified using polyacrylamide gel electrophoresis, followed by
Simply Blue staining (Invitrogen, San Diego, CA) and by Western blotting.
PLG:H7 microparticles were prepared using the water/oil/water solvent evap-
oration technique as previously described (20). Briefly, 100 l of H7 flagellin at
10 mg/ml in distilled water was emulsified with 2 ml of a 5% solution of PLG
(Sigma-Aldrich, St. Louis, MO) in dichloromethane at 16,000 rpm for 2 min
using a T25 Basic Ultra-Turrax homogenizer (IKA-Werke, Staufen, Germany) to
produce a water-in-oil emulsion. The emulsion was subsequently homogenized
with 20 ml of 5% polyvinyl alcohol solution at 19,000 rpm for 2 min to produce
a stable water/oil/water emulsion. The secondary emulsion was stirred for 12 to
18 h at room temperature (RT) and pressure to allow solvent evaporation to
occur and subsequent microparticle preparation. The microparticles were col-
lected by centrifugation, washed three times with distilled water, and lyophilized.
This procedure was repeated on five separate occasions, and the resultant mi-
croparticles were pooled for subsequent immunizations.
The protein content and ratio of surface-bound to encapsulated protein of
each batch of microparticles was assessed using a bicinchoninic protein assay kit
(Pierce, Rockford, IL) following removal of surface protein from a known weight
of microparticles with 2% sodium dodecyl sulfate and subsequent dissolution of
the particles in 0.5 M NaOH to release encapsulated protein. The released
protein was subjected to Western blotting. The particle size and the number of
particles per mg PLG:H7 was estimated using a Z1 Coulter particle counter
(Beckman Coulter Inc., Fullerton, CA).
Western blotting. Samples of H7 flagellin or digested PLG:H7 microspheres
were separated by polyacrylamide gel electrophoresis using NuPAGE 4 onto
12% Bis-Tris gels (Invitrogen) under reducing conditions and transferred to
nitrocellulose membranes (pore size, 0.2 m) using the Xcell II blotting system
(Invitrogen) according to the manufacturer’s instructions. The membranes were
subsequently washed in phosphate-buffered saline (PBS) containing 0.5 M NaCl
and 0.5% (vol/vol) Tween 80 for 1 h at RT. The blots were incubated for 1 h at
RT with rabbit polyclonal anti-H7 antibody (Mast-Assure, Bootle, United King-
dom) diluted 1:500 in PBS containing 0.5 M NaCl and 0.5% (vol/vol) Tween 80,
followed by incubation for 1 h at RT with a 1:2,000 dilution of goat anti-rabbit
polyclonal antibody conjugated to horseradish peroxidase (HRP) (Dakocytoma-
tion, Ely, United Kingdom). Controls included omission of the primary antibody
and replacement of primary antibody with normal rabbit serum. HRP was de-
tected after the final washing by incubating the blots with ECL Plus reagent (GE
Healthcare, Little Chalfont, United Kingdom).
Immunization protocol and oral bacterial challenge. Immunizations and oral
bacterial challenges were performed at the Moredun Research Institute under
Home Office license 60/3179. Ethical approval was obtained from the Moredun
Research Institute Animal Experiments Committee. Four groups of eight con-
ventionally reared male Holstein-Friesian calves were immunized on three sep-
arate occasions at 2-week intervals as follows: group 1 received 60 g H7 flagellin
plus 5 mg Quil A (Brenntag Biosector, Frederikssund, Denmark) in 2 ml PBS
intramuscularly (i.m.); group 2 received 60 g H7 flagellin in 1 ml PBS admin-
istered intrarectally using a pastette inserted approximately 4 cm beyond the
anus; group 3 received 60 g H7 flagellin incorporated into PLG microparticles
and resuspended in 1 ml PBS intrarectally; group 4 received no immunizations
(nonvaccinated control group). The average age of the calves at the time of the
first immunization was 9  2 weeks, and fecal samples obtained from each calf
prior to immunization were confirmed to be negative for E. coli O157:H7 by
immunomagnetic separation performed according to the manufacturer’s instruc-
tions (Dynabeads anti-E. coli O157; Invitrogen).
Ten days after the last immunization, the calves were orally challenged with
1010 CFU naldixic acid-resistant E. coli O157:H7 (stx mutant) strain ZAP198,
and viable E. coli O157:H7 bacteria per gram of surface feces were enumerated
once daily for 3 weeks postchallenge by plating them onto sorbitol MacConkey
agar plates containing 15 g/ml naldixic acid (Oxoid, Basingstoke, United King-
dom) as previously described (31). To estimate the total bacterial fecal shedding,
daily bacterial counts were plotted versus time for each calf, and the area under
the shedding curve (AUC) was calculated. In addition, bacterial uptake rates (as
defined by an increasing fecal bacterial count from 3 days postchallenge) were
recorded. Serum, nasal secretions, and rectal swabs were collected as described
previously (29) 4 days prior to the first immunization, 1 week after each immu-
nization, and 2 weeks after oral bacterial challenge. The calves were euthanized
3 weeks after bacterial challenge, and abomasal and small-intestinal swabs were
collected, in addition to serum, nasal secretions, and rectal swabs.
Quantification of anti-H7 flagellin and anti-O157 LPS antibodies. H7 flagel-
lin-specific immunoglobulin A (IgA) and IgG antibodies were quantified in
serum, nasal secretions, and intestinal-swab samples by indirect enzyme-linked
immunosorbent assay (ELISA) as described previously (29). To measure anti-
O157 lipopolysaccharide (LPS) antibodies, plates were coated with 0.1 g/well
O157 LPS conjugated to polymixin as previously described (9) and subsequently
processed identically to the H7 ELISAs. Optimum sample dilutions were deter-
mined following serial dilution of representatives from each to ensure that the
color reaction product at an optical density at 492 nm (OD492) for the samples
was on the linear part of the curve. Samples were diluted 1:1,000, 1:10, and 1:2.5
for serum, nasal secretions, and intestinal-swab samples, respectively, for IgG
ELISAs and 1:10, 1:100, and 1:2.5 for serum, nasal secretions, and intestinal-
swab samples, respectively, for IgA ELISAs. ODs obtained for intestinal-swab
samples were normalized to the total IgA, measured using a sandwich ELISA
obtained from Bethyl Laboratories Inc. (Montgomery, TX), and interplate vari-
ation was normalized to a positive control. Western blotting was also performed
using ECL Plus reagent (GE Healthcare) on selected preimmunization, postim-
munization, or post-bacterial-challenge serum, nasal secretions, and rectal-swab
samples from each immunization group to confirm the specificity of the antibody
responses measured by ELISA.
Purification of anti-H7 flagellin IgA and IgG. Neat pre- and postimmunization
nasal-secretion samples from five i.m. H7-immunized calves were clarified by
centrifugation at 11,000  g for 5 min. Protein fractionation of 0.5 ml nasal
secretion was carried out by gel filtration chromatography using a Superdex 200
10/300 column and the AKTA fast-protein liquid chromatography system (GE
Healthcare Biosciences AB, Uppsala, Sweden). The column was equilibrated
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with PBS containing 0.04% CHAPS {3-[(3-cholamidopropyl)-dimethylammo-
nio]-1-propanesulfonate} (Sigma-Aldrich), and 1-ml fractions were collected.
Total IgA and IgG were quantified in fractions 7 to 16 using commercial sand-
wich ELISAs (Bethyl Laboratories Inc.). Undiluted fractions were also subjected
to H7-specific IgA and IgG ELISAs. In addition, H7-specific IgM antibodies
were measured by ELISA using anti-bovine IgM conjugated to HRP (AbD
Serotec, Kidlington, United Kingdom).
In vitro intestinal epithelial binding assay. Stationary-phase minimal essential
medium-HEPES cultures of E. coli O157:H7 strain NCTC12900 (which has an
H7 flagellin sequence identical to that of strain ZAP198 used in oral bacterial
challenges) or an isogenic aflagellar mutant strain (3) (both obtained from M. J.
Woodward and R. LaRagione, VLA Weybridge, United Kingdom) were diluted
1:10 in minimal essential medium-HEPES and incubated at 37°C with shaking
(200 rpm) to an OD600 of 0.3 to 0.4. Two hundred-microliter aliquots of bacterial
culture were subsequently incubated for 30 min at RT with 200 l of either
anti-H7 IgA or anti-H7 IgG purified from the nasal secretions of i.m. H7-
immunized calves. Both the IgA and IgG fractions had been previously diluted
to give an OD492 of 1.0 on anti-H7 IgA and IgG ELISA, respectively. Bacteria
were also incubated with an equivalent concentration of total IgA and IgG
purified from the preimmunization nasal secretions of the same calves. Following
antibody incubation, confluent bovine primary rectal epithelial cells prepared as
described previously (12) were separately infected in duplicate with 100 l/well
of each bacterial suspension and incubated for 1 h at 37°C in a humidified 5%
CO2 atmosphere. Nonadherent bacteria were removed by washing them three
times in PBS, and adherent viable bacteria were enumerated following dispersion
with 1% PBS-0.1% (vol/vol) Triton X-100, serial 10-fold dilution, and plating
onto LB agar plates. To account for potential differences in the numbers of
bacteria inoculated into each well, the number of bacteria within each sample
following the antibody incubation step was also determined, and the data were
used to normalize the resultant adherent bacterial counts. The assay was re-
peated with pre- and postimmunization samples derived from five separate
calves.
Statistical analyses. All statistical analyses were performed using the statistical
package Genstat, 7th edition. ELISA and bacterial-shedding data were log10
transformed before analysis to ensure that observations within each group had an
approximately normal distribution with a common variance. ELISA data were
analyzed in two ways: first, data from the different immunization groups 1 week
after the final immunization and at postmortem (for abomasal and small-intes-
tinal swabs only) were compared using one-way analysis of variance (ANOVA);
secondly, differences between postimmunization and post-bacterial-challenge
ELISA data within each immunization group were compared using a paired t
test. A repeated-measures model was fitted to the fecal bacterial shedding data
with the lack of independence between successive measurements on the same
individual modeled with an autoregressive correlation structure. The parameters
of the models were estimated using the REML directive in Genstat. AUC data
from different immunization groups were compared using a Kruskal-Wallis test,
and colonization rates between groups were compared using a Fisher’s exact test.
Bacterial binding data were compared using one-way ANOVA. All ANOVA was
followed by the Tukey post hoc test for pairwise comparison of means. Corre-
lations between normally distributed data were performed using Pearson’s cor-
relation. P values of 0.05 were considered significant.
RESULTS
Characterization of PLG:H7 microparticles. Approximately
94% of the microparticles were 3 m in diameter, with a
further 5% of the particles between 3 and 5 m in diameter.
The efficiency of encapsulation of H7 flagellin into micropar-
ticles ranged between 35 and 40%. Of the total encapsulated
protein, it was estimated that 24 to 35% was surface bound,
with the remaining 65 to 76% internalized into the micropar-
ticles. The number of particles per mg of PLG:H7 of the
pooled microparticles from all batches was estimated to be
approximately 8  106 particles/mg PLG:H7, and each mg of
PLG:H7 was equivalent to 6 g H7. Digestion of micropar-
ticles released a single protein of approximately 60 kDa (Fig.
1A), which reacted strongly with commercial anti-H7 antibody
following Western blotting (Fig. 1B). A band of approximately
120 kDa was also weakly reactive to commercial anti-H7 anti-
body. However, this band is commonly seen in our H7 flagellar
preparations and has been previously identified as H7 flagellin
by matrix-assisted laser desorption ionization–time of flight
mass spectrometry (27), suggesting that the band may repre-
sent H7 with posttranslational modifications or H7 dimers.
H7-specific antibody responses following immunization with
H7 flagellin and subsequent oral bacterial challenge. Serum,
nasal, and rectal H7-specific antibody responses are shown in
Fig. 2. High titers of anti-H7 IgG and IgA were induced in both
serum and nasal secretions following i.m. injection of H7, and
IgA antibody levels reached peak levels after the second im-
munization, whereas IgG antibody levels continued to rise
(Fig. 2A to D). In contrast, per-rectal immunization with either
H7 or PLG:H7 failed to induce any significant serum or nasal
H7-specific antibody response. Subsequent oral challenge with
E. coli O157:H7 resulted in a small but significant increase in
serum anti-H7 IgG within all immunized and control groups
compared to postimmunization levels (P  0.01 for all groups)
(Fig. 2A). Bacterial challenge also resulted in a small but
significant increase in nasal anti-H7 IgG (P  0.05) (Fig. 2C)
and a significant increase in nasal and serum IgA in animals
from rectally immunized and control groups, but not from i.m.
immunized calves (P  0.01 for both) (Fig. 2B and D).
Anti-H7 IgG antibodies were detected in rectal-swab sam-
ples following i.m. immunization with H7, but not with any
other immunization group (Fig. 2E). Rectal H7-specific IgA
antibodies were induced following both i.m. vaccination and
rectal immunization with H7 in PBS, and 1 week after the final
immunization (day 42), the levels of anti-H7 IgA were similar
in the two groups (Fig. 2F). In contrast, rectal immunization
with PLG:H7 failed to induce any rectal anti-H7 IgA antibod-
ies. Following bacterial challenge, a significant increase in rec-
tal anti-H7 IgA, but not IgG, was observed in both rectally
immunized groups and the nonvaccinated control group (P 
0.01 for all groups). No significant increase in H7-specific IgA
or IgG was observed in i.m. vaccinated calves in response to
bacterial challenge.
Postmortem abomasal and small-intestinal H7-specific anti-
body levels are shown in Fig. 3. Significantly higher levels of
anti-H7 IgG antibodies were found in the abomasum and small
FIG. 1. Evaluation of PLG:H7 microparticles by polyacrylamide
gel electrophoresis and Western blot analysis. (A) Coomassie blue-
stained gel of protein released from PLG microparticles following
dissolution with sodium dodecyl sulfate and NaOH. (B) Western blot
of protein released from PLG microparticles with rabbit polyclonal
anti-H7 antibody (lane 1), normal rabbit serum (lane 2), or no primary
antibody (lane 3).
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intestines of i.m. immunized calves compared to rectally im-
munized and nonvaccinated calves (one-way ANOVA; main P
values for both  0.0001; significance at the 1% level using
Tukey’s pairwise comparisons). No differences in abomasal or
small-intestinal H7-specific IgA levels were observed between
immunization groups.
Western blotting was performed on selected preimmuniza-
tion, postimmunization, or post-bacterial-challenge samples
from each immunization group. This confirmed that immuno-
reactivity was primarily directed against H7 flagellin (data not
shown).
Correlation between H7- and LPS-specific antibody re-
sponses following oral bacterial challenge. Oral bacterial chal-
lenge with E. coli O157:H7 resulted in an increase in H7-
specific IgA antibodies in mucosal and serum samples from all
groups, with the exception of the i.m. immunized group. To
determine whether H7 responses following bacterial challenge
in the i.m. immunized group were correlated with levels of
FIG. 2. Levels of H7-specific IgG and IgA measured by ELISA in serum (A and B), nasal secretions (C and D), and rectal-swab samples (E
and F) from calves following either systemic or mucosal immunization with H7 flagellin. The values represent the mean value the standard error
of the mean for eight calves at each time point. The solid arrows indicate the timing of immunizations; the open arrow indicates the timing of
subsequent oral bacterial challenge with E. coli O157:H7. IM H7, i.m. H7; PR H7, rectal immunization with H7 in PBS; PR PLG:H7, rectal
immunization with H7 encapsulated in PLG microparticles; NVC, nonvaccinated controls.
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bacterial colonization, anti-O157 LPS IgA antibodies (used as
an indicator of E. coli O157:H7 mucosal immune responses)
(30) were measured in serum, nasal secretions, and rectal-swab
samples in i.m. immunized and nonvaccinated calves 12 days
post-bacterial challenge. Correlations between anti-H7 and
LPS IgA responses at day 12 postchallenge are shown in Table
1. In nonvaccinated calves, there was a significant positive
correlation between anti-H7 and LPS antibody responses in
serum, nasal secretions, and rectal-swab samples. In i.m. im-
munized calves, a significant positive correlation existed be-
tween H7 and LPS antibody levels in rectal swabs, but not in
serum or nasal secretions.
E. coli O157:H7 colonization following immunization with
H7 flagellin. Following immunization, oral bacterial challenge
with E. coli O157:H7 resulted in successful colonization of
three of eight calves in the i.m. immunized group compared to
100% of rectally immunized and six of eight nonvaccinated
calves. Comparison of uptake rates between groups using Fish-
er’s exact test identified significant differences in uptake rates
between the groups (P  0.006), with the i.m. immunized
group having a markedly lower uptake rate than the other
groups.
Daily mean bacterial counts for colonized calves only are
shown in Fig. 4A. There was an overall immunization times
time interaction (P  0.009) that was reflected in higher
mean bacterial counts in the i.m. immunized group com-
pared to rectally immunized and control groups on days 12
and 13. No differences in mean bacterial counts were iden-
tified between groups at other time points. Peak bacterial
shedding occurred between days 10 and 14 in colonized
calves from the i.m. immunized group, whereas peak shed-
ding in colonized calves from rectally immunized and con-
trol groups occurred between days 5 and 8. To estimate total
bacterial shedding, AUCs were calculated for each calf and
are shown in Fig. 4B. No significant differences in AUCs
were identified between immunization and control groups,
FIG. 3. Levels of H7-specific IgG and IgA measured by ELISA in abomasal (A and B) and small-intestinal (C and D) swabs of calves at
postmortem following either systemic or mucosal immunization with H7 and subsequent oral challenge with E. coli O157:H7. The values represent
the mean value standard error of the mean for eight calves at each time-point. **, significantly different from the other three groups by ANOVA
(main P value  0.0001; significance at the 1% level using Tukey’s pairwise comparisons). IM H7, i.m. H7; PR H7, rectal immunization with H7
in PBS; PR PLG:H7, rectal immunization with H7 encapsulated in PLG microparticles; NVC, nonvaccinated controls.
TABLE 1. Correlation coefficients between anti-H7 and anti-O157
LPS IgA antibodies following oral challenge with E. coli O157:H7
Sample
i.m. H7-immunized
group Nonvaccinated group
ra P value ra P value
Serum 0.456 0.303 0.900 0.002
Nasal secretions 0.524 0.182 0.861 0.006
Rectal swabs 0.865 0.006 0.879 0.004
a Pearson’s correlation coefficient calculated using log-transformed data.
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indicating no differences in total bacterial shedding between
these groups.
Effects of anti-H7 IgA and IgG on intestinal epithelial bind-
ing of E. coli O157:H7 in vitro. To determine if anti-H7 IgG
and/or IgA isotypes are effective at inhibiting E. coli O157:H7
intestinal epithelial binding, wild-type E. coli O157:H7 or an
isogenic aflagellar mutant strain was incubated with either
anti-H7 IgG or IgA purified by gel filtration chromatography
from nasal secretions derived from five i.m. immunized calves,
and subsequent bacterial binding to bovine primary rectal ep-
ithelial cells was evaluated. Gel filtration fractions were ana-
lyzed for total IgA/IgG and H7-specific IgA/IgG. A represen-
tative graph of total IgA and IgG levels in fractions obtained
from one calf is shown in Fig. 5A, and a graph of anti-H7
antibody levels in fractions from pre- and postimmunization
nasal secretions from the same calf is shown in Fig. 5B. IgA
was present in fractions 7 to 11 from all calves, with maximal
total IgA present in fraction 9. The peak total IgG concentra-
tion was present in fraction 12, with small quantities of IgG
present in fractions 7 to 9. Measurement of anti-H7 IgA and
IgG antibodies in postimmunization fractions revealed maxi-
mal anti-H7 IgA and IgG antibodies in fractions 9 and 12,
respectively. No anti-H7 IgA was detected in IgG-enriched
fractions. However, some anti-H7 IgG activity was detected in
IgA-enriched fractions. Minimal reactivity to anti-H7 IgA and
IgG ELISAs was observed in fractions obtained from preim-
mune nasal secretions from the same calves. Anti-H7 IgM
antibodies were also measured in all fractions and were not
detected (data not shown).
The effects of anti-H7 IgA- or IgG-enriched fractions (9 and
12, respectively) on epithelial binding are shown in Fig. 5C and
D. Incubation of wild-type E. coli O157:H7 with both anti-H7
IgA and IgG fractions resulted in a significant reduction in
bacterial binding to bovine rectal epithelial cells compared to
incubation with preimmune IgA and IgG fractions (Fig. 5C),
with both isotypes inhibiting bacterial binding to similar de-
FIG. 4. Fecal shedding of E. coli O157:H7 following oral challenge of calves previously vaccinated either systemically or mucosally with H7
flagellin. The calves were immunized on three separate occasions and challenged 10 days after the final immunization. (A) Mean daily fecal
count  standard error of the mean for colonized calves only. (B) Rug plot of AUC data calculated over the total 21-day shedding period for each
calf. Each horizontal line indicates an individual value for each calf. IM H7, i.m. H7; PR H7, rectal immunization with H7 in PBS; PR PLG:H7,
rectal immunization with H7 encapsulated in PLG microparticles; NVC, nonvaccinated controls.
VOL. 76, 2008 VACCINATION AGAINST E. COLI O157:H7 USING H7 FLAGELLIN 2599
grees (one-way ANOVA; main P value  0.0001; significance
at the 1% level using Tukey’s pairwise comparisons). No sig-
nificant differences in bacterial binding were observed follow-
ing incubation of the isogenic aflagellar mutant strain with
either antibody isotype (Fig. 5D), indicating that the observed
inhibition of bacterial binding was a flagellin-specific effect.
DISCUSSION
Systemic immunization with H7 flagellin resulted in reduced
colonization rates and delayed peak bacterial shedding in col-
onized calves by approximately 1 week. However, no effect on
total bacterial shedding following systemic immunization was
observed. In contrast, rectal immunization with either H7
alone or H7 incorporated into PLG microparticles had no
effect on subsequent bacterial colonization or shedding. Alter-
ations in bacterial shedding following systemic H7 immuniza-
tion correlated with a widespread mucosal antibody response
to H7 consisting of both IgG and IgA isotypes: anti-H7 IgG
was detectable postmortem throughout the gastrointestinal
tract, and anti-H7 IgA was detectable in both rectal-swab sam-
ples and nasal secretions, suggesting that i.m. immunization
resulted in induction of an IgA response at multiple mucosal
sites. The lack of any effect on bacterial colonization following
rectal immunization with H7 in PBS occurred despite induc-
tion of a local (rectal) IgA response. Immunization with
PLG:H7 failed to induce any detectable anti-H7 antibodies,
possibly due to either insufficient uptake of antigen at the
rectal mucosa or alterations of the flagellin epitopes during the
encapsulation process. However, the former is more likely than
the latter, as Western blotting of flagellin released from the
microparticles demonstrated that the released flagellin re-
tained at least a proportion of its B-cell epitopes.
Western blotting demonstrated that the majority of antibody
responses induced following vaccination were directed against
H7 flagellin. This suggests that the slight protective responses
observed in this study were primarily due to immune responses
against the flagellin protein. However, we cannot rule out the
possibility that other minor contaminants within the vaccine
preparation, such as LPS, may have contributed to the altered
bacterial shedding observed in i.m. immunized calves. Never-
FIG. 5. (A) Total IgA and IgG levels in gel filtration fractions of nasal secretions from one calf immunized with H7 flagellin by the i.m. route.
(B) Levels of H7-specific IgA and IgG in gel filtration fractions determined by ELISA from one calf before and after i.m. immunization with H7
flagellin. (C) Adherence of E. coli O157:H7 strain NCTC12900 to bovine primary rectal epithelial cells after incubation with IgA- or IgG-rich gel
filtration fractions (9 and 12, respectively) derived from nasal-secretion samples from calves pre- and post-i.m. immunization with H7 flagellin.
(D) Adherence of an isogenic aflagellar mutant strain of E. coli O157:H7 strain NCTC12900 to bovine primary rectal epithelial cells after
incubation with IgA- or IgG-rich gel filtration fractions derived from nasal-secretion samples from calves pre- and post-i.m. immunization with H7
flagellin. The values represent the mean number of adhering bacteria  standard error of the mean following incubation with samples obtained
from five calves. **, significantly different from counts obtained following incubation with preimmune fractions by ANOVA (main P value 
0.0001; significance at the 1% level using Tukey’s pairwise comparisons).
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theless, by purifying flagellin from a stx mutant LEE4 deletion
mutant strain of E. coli O157:H7, we could at least be confident
that our vaccines were not contaminated with proteins en-
coded by the LEE4 operon, known to be required for epithelial
colonization (32), or Shiga toxin.
Although different strains of E. coli O157:H7 were used for
in vitro binding assays and oral challenges, which may differ
slightly in their epithelial binding dynamics, both strains shared
identical H7 flagellin sequences. Therefore, the observation
that both IgA and IgG isotypes were effective at inhibiting
bacterial binding in vitro in an H7-specific manner suggests
that these anti-H7 antibodies may have been similarly effective
at inhibiting bacterial epithelial binding in vivo. As both IgA
and IgG isotypes are key immunoglobulins present in bovine
intestinal secretions (6, 33), this raises two possible explana-
tions for the altered bacterial shedding observed following i.m.
immunization but not rectal immunization with H7. First,
anti-H7 antibodies may be required throughout the whole in-
testinal tract and not just at the rectum to have an effect on
subsequent E. coli O157:H7 colonization in vivo. This appears
likely, as, although E. coli O157:H7 preferentially colonizes at
the terminal rectal mucosa, the bacterium also colonizes at
other intestinal sites, including the forestomachs, abomasum,
duodenum, ileum, cecum, and colon (4, 8, 31). Secondly, as
combined levels of H7-specific IgG and IgA antibodies were
higher at the rectal mucosa following i.m. immunization than
following rectal H7 immunization, it may be that the overall
quantity of anti-H7 antibodies at the terminal rectum is crucial
for altering bacterial colonization in vivo. In either case, the
effect of i.m. immunization with H7 appeared to be restricted
to either a reduction in initial bacterial uptake or a delay in
peak colonization but had no effect on the ability of the bac-
teria to reach high levels in colonized calves.
It was shown in this study that anti-H7 antibodies resulted in
around a 50% reduction, but not complete elimination, of
bacterial epithelial binding in vitro. This suggests that E. coli
O157:H7 possesses additional mechanisms for intestinal epi-
thelial attachment beyond H7-flagellin-mediated processes. In-
deed, a recent study in cattle has demonstrated that knocking
out the gene encoding H7 flagellin (fliC) had no significant
effect on subsequent colonization of cattle with E. coli O157,
indicating that intestinal epithelial binding in vivo can occur
independently of H7 (11). Therefore, the results from this
study indicate that although H7 flagellin may be a useful com-
ponent in a systemic vaccine against E. coli O157:H7 in cattle,
additional bacterial antigens would need to be included to
significantly reduce total bacterial fecal shedding.
An interesting finding in this study is that an H7-specific
mucosal IgA response was induced in both nasal secretions and
rectal-swab samples following i.m. immunization with H7. This
finding is unusual, as systemic routes of immunization gener-
ally result in poor mucosal IgA levels (23, 24). However, con-
fidence in the result can be gained by the following observa-
tions: first, previous analyses of the mucosal sampling
techniques employed in this study have shown that the majority
of IgA present in the mucosal samples is locally, i.e., mucosally
derived (29). Secondly, analysis of gel filtration fractions of
nasal secretions from i.m. immunized calves indicate that the
anti-bovine IgA antibodies employed in the H7 ELISA do not
appear to cross-react with bovine IgG to any great extent.
The underlying mechanisms of mucosal response generation
following systemic H7 immunization are unclear. It may be
that the calves in this study were mucosally primed to either H7
flagellin or other E. coli flagellins, which share highly con-
served regions at the N and C termini (42), prior to immuni-
zation, as it has been shown that prior mucosal priming is
required to generate an intestinal antigen-specific IgA re-
sponse to systemic immunization with either trinitrophenyl-
keyhole limpet hemocyanin or inactivated polio vaccine in
mice and humans, respectively (18, 21). A second possibility is
that the mucosal IgA response induced by systemically admin-
istered H7 represents an inherent capability of H7 to direct
immune responses toward the mucosal surfaces.
Finally, further intriguing findings in this study relate to the
dynamics of the antibody response generated by i.m. immuni-
zation of H7. First, peak IgA levels occurred after the second
immunization in both serum and nasal secretions, whereas
H7-specific IgG continued to rise after the third immunization.
One possible explanation is that flagellin administered on the
third immunization was excluded or blocked by preexisting
antibodies and therefore was not available to stimulate further
antibody production. The subsequent fall in H7-specific IgA,
but not IgG, could be explained by differences in their respec-
tive half-lives: serum half-lives of IgA and IgG in calves have
been estimated to be approximately 2.5 days for IgA and 16
days for IgG (5). Therefore, if the third immunization failed to
induce any further antibody production, H7-specific IgA would
fall whereas IgG levels would be maintained for a longer pe-
riod.
Secondly, whereas oral bacterial challenge with E. coli
O157:H7 resulted in an increase in H7-specific IgA antibodies
in mucosal and serum samples from unvaccinated and muco-
sally immunized calves, no such increase in anti-H7 IgA oc-
curred in the i.m. immunized group. However, as a significant
positive correlation existed between levels of anti-H7 and anti-
O157 LPS IgA in postchallenge rectal-swab samples from both
systemically immunized and nonvaccinated calves, it is likely
that the lack of an obvious increase in anti-H7 IgA in the i.m.
immunized group was, at the rectum at least, due to lower
levels of bacterial colonization. The lack of a correlation be-
tween levels of H7 and LPS IgA in postchallenge serum and
nasal secretions from i.m. immunized calves could be explained
by the existence of high levels of vaccine-induced anti-H7 IgA
antibodies in these samples prior to oral challenge.
In conclusion, we have shown that systemic, but not rectal,
immunization of cattle with H7 flagellin resulted in reduced
colonization rates and delayed peak shedding of E. coli
O157:H7 following experimental challenge but did not affect
total bacterial fecal shedding. This effect was associated with a
widespread systemic and mucosal antibody response. Further-
more, both anti-IgA and -IgG antibodies were shown to inhibit
binding of E. coli O157:H7 to the intestinal epithelium in vitro.
These results indicate that H7 flagellin may be a useful com-
ponent of a systemic vaccination against E. coli O157:H7 in
cattle.
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